Quick Answer
Inogen Inc reported Total Revenue of $348.67 million for fiscal year 2025.
Inogen Inc — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $348.67M +3.9% |
$335.70M +6.4% |
$315.66M -16.3% |
$377.24M +5.4% |
$358.00M +16.1% |
$308.49M -14.8% |
| Revenue (ASC 606) | $295.30M +5.9% |
$278.76M +10.8% |
$251.61M -21.5% |
$320.55M +2.8% |
$311.73M +11.3% |
$280.19M -17.7% |
| Net Income | -$22.75M +36.6% |
-$35.89M +65.0% |
-$102.45M -22.3% |
-$83.77M -1222.8% |
-$6.33M -8.6% |
-$5.83M -127.8% |
| Diluted EPS | -$0.86 +43.4% |
-$1.52 +65.6% |
-$4.42 -20.4% |
-$3.67 -1210.7% |
-$0.28 -3.7% |
-$0.27 -128.7% |
| Total Assets | $298.62M +0.8% |
$296.19M -9.2% |
$326.19M -19.5% |
$405.04M -17.3% |
$489.51M +6.0% |
$461.85M +3.2% |
| Cash and Equivalents | $103.73M -8.8% |
$113.80M -9.3% |
$125.49M -32.9% |
$187.01M -20.6% |
$235.52M +11.1% |
$211.96M +7.0% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | $192.23M +10.6% |
$173.86M -15.1% |
$204.81M -31.1% |
$297.41M -19.7% |
$370.23M +5.9% |
$349.62M +1.5% |
| R&D Expense | $19.40M -10.2% |
$21.61M +3.7% |
$20.84M -5.0% |
$21.94M +32.4% |
$16.58M +17.7% |
$14.08M +49.8% |
| Operating Income | -$30.21M +29.0% |
-$42.52M +61.1% |
-$109.39M -28.3% |
-$85.24M -1022.5% |
$9.24M +176.8% |
-$12.03M -160.8% |
| Gross Profit | $154.26M -0.3% |
$154.74M +22.1% |
$126.70M -17.5% |
$153.53M -13.0% |
$176.48M +27.7% |
$138.18M -19.6% |
| Shares Outstanding | 27.23M +13.9% |
23.90M +2.5% |
23.32M +1.7% |
22.94M +0.9% |
22.73M +2.7% |
22.13M +0.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $92.39M | +4.0% | +0.1% |
| Revenue (ASC 606) | September 30, 2025 | $79.09M | +5.6% | -0.1% |
| Net Income | September 30, 2025 | -$5.29M | +11.2% | -27.5% |
| Diluted EPS | September 30, 2025 | -$0.20 | +20.0% | -33.3% |
| Total Assets | September 30, 2025 | $307.01M | +0.3% | -1.6% |
| Cash and Equivalents | September 30, 2025 | $106.48M | +0.7% | +2.7% |
| Long-Term Debt | September 30, 2015 | $80.0K | -79.5% | -49.7% |
| Stockholders Equity | September 30, 2025 | $197.18M | +6.3% | -1.2% |
| R&D Expense | September 30, 2025 | $4.84M | +37.6% | -7.1% |
| Operating Income | September 30, 2025 | -$7.12M | +8.7% | -16.1% |
| Gross Profit | September 30, 2025 | $41.32M | -0.1% | -0.1% |
| Shares Outstanding | September 30, 2025 | 27.15M | +14.0% | +0.4% |
- Inogen Inc reported Total Revenue of $348.67 million for fiscal year 2025.
- Inogen Inc showed an increase of +3.9% in Total Revenue compared to the prior fiscal year.
- Inogen Inc reported Revenue (ASC 606) of $295.30 million for fiscal year 2025.
- Inogen Inc showed an increase of +5.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Inogen Inc reported Net Income of -$22.75 million for fiscal year 2025.
- Inogen Inc showed an increase of +36.6% in Net Income compared to the prior fiscal year.
- Inogen Inc reported Diluted EPS of $0.86 per share (loss) for fiscal year 2025.
- Inogen Inc showed an increase of +43.4% in Diluted EPS compared to the prior fiscal year.
- Inogen Inc reported Total Assets of $298.62 million for fiscal year 2025.
- Inogen Inc showed an increase of +0.8% in Total Assets compared to the prior fiscal year.
- Inogen Inc reported Cash and Equivalents of $103.73 million for fiscal year 2025.
- Inogen Inc showed a decrease of -8.8% in Cash and Equivalents compared to the prior fiscal year.
- Inogen Inc reported Long-Term Debt of $315.0 thousand for fiscal year 2014.
- Inogen Inc showed a decrease of -94.2% in Long-Term Debt compared to the prior fiscal year.
- Inogen Inc reported Stockholders Equity of $192.23 million for fiscal year 2025.
- Inogen Inc showed an increase of +10.6% in Stockholders Equity compared to the prior fiscal year.
- Inogen Inc reported R&D Expense of $19.40 million for fiscal year 2025.
- Inogen Inc showed a decrease of -10.2% in R&D Expense compared to the prior fiscal year.
- Inogen Inc reported Operating Income of -$30.21 million for fiscal year 2025.
- Inogen Inc showed an increase of +29.0% in Operating Income compared to the prior fiscal year.
- Inogen Inc reported Gross Profit of $154.26 million for fiscal year 2025.
- Inogen Inc showed a decrease of -0.3% in Gross Profit compared to the prior fiscal year.
- Inogen Inc reported Shares Outstanding of 27.23 million shares for fiscal year 2025.
- Inogen Inc showed an increase of +13.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: